Anant Raj Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 8:12 pm

Quick Insight

Anant Raj Ltd, currently trading at ₹567, exhibits a market capitalization of ₹19,463 crore, reflecting robust investor interest, particularly with a promoter stake of 60.01%. The company’s P/E ratio of 42.3 suggests a premium valuation, potentially driven by a net profit of ₹426 crore and an ROE of 10.9%. With an operating profit margin of 26% and a commendable interest coverage ratio (ICR) of 10.73x, Anant Raj appears financially sound. However, the price-to-book value of 2.91x indicates the stock might be overvalued relative to its book value. Given its solid fundamentals and moderate borrowing of ₹482 crore against reserves of ₹4,092 crore, investors should consider the potential for growth in the realty sector, albeit with caution regarding the high valuation metrics.

Competitors of Anant Raj Ltd

All Competitor Stocks of Anant Raj Ltd

Quarterly Result

Last Updated: August 2, 2025, 12:20 am

Below is a detailed analysis of the quarterly data for Anant Raj Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 592.00 Cr.. The value appears strong and on an upward trend. It has increased from 541.00 Cr. (Mar 2025) to 592.00 Cr., marking an increase of 51.00 Cr..
• For Expenses, as of Jun 2025, the value is 442.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 398.00 Cr. (Mar 2025) to 442.00 Cr., marking an increase of 44.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 151.00 Cr.. The value appears strong and on an upward trend. It has increased from 142.00 Cr. (Mar 2025) to 151.00 Cr., marking an increase of 9.00 Cr..
• For OPM %, as of Jun 2025, the value is 25.00%. The value appears to be declining and may need further review. It has decreased from 26.00% (Mar 2025) to 25.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
• For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 8.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 150.00 Cr.. The value appears strong and on an upward trend. It has increased from 141.00 Cr. (Mar 2025) to 150.00 Cr., marking an increase of 9.00 Cr..
• For Tax %, as of Jun 2025, the value is 17.00%. The value appears to be increasing, which may not be favorable. It has increased from 16.00% (Mar 2025) to 17.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 126.00 Cr.. The value appears strong and on an upward trend. It has increased from 119.00 Cr. (Mar 2025) to 126.00 Cr., marking an increase of 7.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.67. The value appears strong and on an upward trend. It has increased from 3.46 (Mar 2025) to 3.67, marking an increase of 0.21.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 3, 2025, 3:15 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 3:53 pm

Below is a detailed analysis of the balance sheet data for Anant Raj Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 69.00 Cr.. The value appears strong and on an upward trend. It has increased from 68.00 Cr. (Mar 2024) to 69.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 4,092.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,588.00 Cr. (Mar 2024) to 4,092.00 Cr., marking an increase of 504.00 Cr..
• For Borrowings, as of Mar 2025, the value is 482.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 627.00 Cr. (Mar 2024) to 482.00 Cr., marking a decrease of 145.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 592.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 585.00 Cr. (Mar 2024) to 592.00 Cr., marking an increase of 7.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 5,235.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,868.00 Cr. (Mar 2024) to 5,235.00 Cr., marking an increase of 367.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,367.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,314.00 Cr. (Mar 2024) to 1,367.00 Cr., marking an increase of 53.00 Cr..
• For CWIP, as of Mar 2025, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2024) to 36.00 Cr., marking an increase of 14.00 Cr..
• For Investments, as of Mar 2025, the value is 311.00 Cr.. The value appears strong and on an upward trend. It has increased from 302.00 Cr. (Mar 2024) to 311.00 Cr., marking an increase of 9.00 Cr..
• For Other Assets, as of Mar 2025, the value is 3,520.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,231.00 Cr. (Mar 2024) to 3,520.00 Cr., marking an increase of 289.00 Cr..
• For Total Assets, as of Mar 2025, the value is 5,235.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,868.00 Cr. (Mar 2024) to 5,235.00 Cr., marking an increase of 367.00 Cr..

Notably, the Reserves (4,092.00 Cr.) exceed the Borrowings (482.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Anant Raj Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 7.96. This value is within the healthy range. It has increased from 4.73 (Mar 23) to 7.96, marking an increase of 3.23.
• For Diluted EPS (Rs.), as of Mar 24, the value is 7.96. This value is within the healthy range. It has increased from 4.88 (Mar 23) to 7.96, marking an increase of 3.08.
• For Cash EPS (Rs.), as of Mar 24, the value is 8.27. This value is within the healthy range. It has increased from 4.96 (Mar 23) to 8.27, marking an increase of 3.31.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 107.77. It has increased from 88.19 (Mar 23) to 107.77, marking an increase of 19.58.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 107.77. It has increased from 88.19 (Mar 23) to 107.77, marking an increase of 19.58.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 43.38. It has increased from 29.53 (Mar 23) to 43.38, marking an increase of 13.85.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 10.86. This value is within the healthy range. It has increased from 7.56 (Mar 23) to 10.86, marking an increase of 3.30.
• For PBIT / Share (Rs.), as of Mar 24, the value is 10.33. This value is within the healthy range. It has increased from 7.05 (Mar 23) to 10.33, marking an increase of 3.28.
• For PBT / Share (Rs.), as of Mar 24, the value is 9.32. This value is within the healthy range. It has increased from 6.07 (Mar 23) to 9.32, marking an increase of 3.25.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 7.74. This value is within the healthy range. It has increased from 4.46 (Mar 23) to 7.74, marking an increase of 3.28.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 7.78. This value is within the healthy range. It has increased from 4.66 (Mar 23) to 7.78, marking an increase of 3.12.
• For PBDIT Margin (%), as of Mar 24, the value is 25.02. This value is within the healthy range. It has decreased from 25.60 (Mar 23) to 25.02, marking a decrease of 0.58.
• For PBIT Margin (%), as of Mar 24, the value is 23.81. This value exceeds the healthy maximum of 20. It has decreased from 23.87 (Mar 23) to 23.81, marking a decrease of 0.06.
• For PBT Margin (%), as of Mar 24, the value is 21.47. This value is within the healthy range. It has increased from 20.55 (Mar 23) to 21.47, marking an increase of 0.92.
• For Net Profit Margin (%), as of Mar 24, the value is 17.83. This value exceeds the healthy maximum of 10. It has increased from 15.09 (Mar 23) to 17.83, marking an increase of 2.74.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 17.92. This value is within the healthy range. It has increased from 15.79 (Mar 23) to 17.92, marking an increase of 2.13.
• For Return on Networth / Equity (%), as of Mar 24, the value is 7.27. This value is below the healthy minimum of 15. It has increased from 5.34 (Mar 23) to 7.27, marking an increase of 1.93.
• For Return on Capital Employeed (%), as of Mar 24, the value is 8.01. This value is below the healthy minimum of 10. It has increased from 5.74 (Mar 23) to 8.01, marking an increase of 2.27.
• For Return On Assets (%), as of Mar 24, the value is 5.46. This value is within the healthy range. It has increased from 3.46 (Mar 23) to 5.46, marking an increase of 2.00.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.12. This value is below the healthy minimum of 0.2. It has decreased from 0.31 (Mar 23) to 0.12, marking a decrease of 0.19.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.17. This value is within the healthy range. It has decreased from 0.33 (Mar 23) to 0.17, marking a decrease of 0.16.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.32. It has increased from 0.15 (Mar 23) to 0.32, marking an increase of 0.17.
• For Current Ratio (X), as of Mar 24, the value is 5.90. This value exceeds the healthy maximum of 3. It has increased from 5.70 (Mar 23) to 5.90, marking an increase of 0.20.
• For Quick Ratio (X), as of Mar 24, the value is 2.85. This value exceeds the healthy maximum of 2. It has increased from 2.57 (Mar 23) to 2.85, marking an increase of 0.28.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 6.09. This value is below the healthy minimum of 20. It has increased from 2.34 (Mar 23) to 6.09, marking an increase of 3.75.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 5.70. This value is below the healthy minimum of 20. It has increased from 2.11 (Mar 23) to 5.70, marking an increase of 3.59.
• For Earning Retention Ratio (%), as of Mar 24, the value is 93.91. This value exceeds the healthy maximum of 70. It has decreased from 97.66 (Mar 23) to 93.91, marking a decrease of 3.75.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 94.30. This value exceeds the healthy maximum of 70. It has decreased from 97.89 (Mar 23) to 94.30, marking a decrease of 3.59.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 10.73. This value is within the healthy range. It has increased from 7.71 (Mar 23) to 10.73, marking an increase of 3.02.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 8.64. This value is within the healthy range. It has increased from 5.55 (Mar 23) to 8.64, marking an increase of 3.09.
• For Enterprise Value (Cr.), as of Mar 24, the value is 10,985.30. It has increased from 4,864.34 (Mar 23) to 10,985.30, marking an increase of 6,120.96.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 7.41. This value exceeds the healthy maximum of 3. It has increased from 5.08 (Mar 23) to 7.41, marking an increase of 2.33.
• For EV / EBITDA (X), as of Mar 24, the value is 29.59. This value exceeds the healthy maximum of 15. It has increased from 19.86 (Mar 23) to 29.59, marking an increase of 9.73.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 7.18. This value exceeds the healthy maximum of 3. It has increased from 4.15 (Mar 23) to 7.18, marking an increase of 3.03.
• For Retention Ratios (%), as of Mar 24, the value is 93.90. This value exceeds the healthy maximum of 70. It has decreased from 97.65 (Mar 23) to 93.90, marking a decrease of 3.75.
• For Price / BV (X), as of Mar 24, the value is 2.91. This value is within the healthy range. It has increased from 1.40 (Mar 23) to 2.91, marking an increase of 1.51.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 7.18. This value exceeds the healthy maximum of 3. It has increased from 4.15 (Mar 23) to 7.18, marking an increase of 3.03.
• For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 23) to 0.02, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness